A WHO-developed app uses AI image recognition to help health workers in low-income countries identify skin conditions, including those affecting people with albinism.
In many low- and middle-income countries, a frontline health worker may be the only medical contact a patient sees for months. When that worker has no dermatology training, conditions that present on the skin — including those common among people with albinism — can go unrecognised and untreated.
The World Health Organization developed a mobile application specifically to close that gap. Built by UniversalDoctor, the Skin NTDs App was originally a digital version of a WHO training guide for neglected tropical diseases that affect the skin. According to the Journal of Investigative Dermatology, the app has since expanded considerably.
From training guide to clinical tool
The app now incorporates a clinical decision support tool developed by Until No Leprosy Remains, a second-opinion pathway for complex cases. More recently, the Journal of Investigative Dermatology reported, the WHO integrated an artificial intelligence-powered visual classifier — a tool that analyses photographs of skin conditions and returns a probable diagnosis.
That addition matters in settings where a health worker might encounter an unfamiliar presentation and have no specialist to consult. The AI component is designed to support, not replace, clinical judgement, according to the journal's account of the app's development.
What this means for people with albinism
For people with albinism, skin health is a sustained, lifelong concern. Without melanin, the skin has no natural defence against ultraviolet radiation. In Sub-Saharan Africa, where sun exposure is intense and dermatology services are sparse, skin cancers among people with albinism are diagnosed late — often at stages that limit treatment options, according to existing public health literature.
A tool that trains frontline workers to recognise and respond to skin conditions in under-resourced settings could, over time, improve the likelihood of earlier referral and care for people with albinism who live far from specialist facilities.
The Journal of Investigative Dermatology described the app as a dynamic capacity-building tool — one that can be updated as clinical evidence evolves and as AI classifiers are trained on broader datasets.
The WHO has not yet published outcome data on how the app performs in the field, and the journal's article stops short of evaluating real-world impact. What it documents is a platform with the structural capacity to grow.
For communities where a missed skin diagnosis can become a life-threatening delay, that architecture is worth watching.
Keywords
Core topics and entities mentioned in this summary.